Back
Pacific Biosciences of California, Inc. 10K Form
Buy
71
PACB
Pacific Biosciences of California, Inc.
Last Price:
$2.53
Seasonality Move:
16.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | PACB/Pacific Biosciences of California, Inc. Quarterly |
| 2024-02-28 | 10K | PACB/Pacific Biosciences of California, Inc. Annual |
| 2023-11-03 | 10Q | PACB/Pacific Biosciences of California, Inc. Quarterly |
| 2023-08-04 | 10Q | PACB/Pacific Biosciences of California, Inc. Quarterly |
| 2023-05-04 | 10Q | PACB/Pacific Biosciences of California, Inc. Quarterly |
| 2023-02-28 | 10K | PACB/Pacific Biosciences of California, Inc. Annual |
Receive PACB News And Ratings
See the #1 stock for the next 7 days that we like better than PACB
PACB Financial Statistics
Sales & Book Value
| Annual Sales: | $154M |
|---|---|
| Cash Flow: | $-18.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.12 |
| Price / Book: | 21.08 |
Profitability
| EPS (TTM): | -2.17580 |
|---|---|
| Net Income (TTM): | $-502.4M |
| Gross Margin: | $23.7M |
| Return on Equity: | -218.65% |
| Return on Assets: | -48.31% |
Pacific Biosciences of California, Inc. Earnings Forecast
Key Pacific Biosciences of California, Inc. Financial Ratios
-
The Gross Profit Margin over the past 18 years for PACB is 15.37%.
-
The Selling, General & Administrative Expenses for PACB have been equal to 113.64% of Gross Profit Margin.
-
The Research & Development expenses have been 83.77% of Revenue.
-
The Net Earning history of PACB is -201.18% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 10 years.
Pacific Biosciences of California, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | PACB |
| CUSIP: | 69404D |
| Website: | pacb.com |
Debt
| Debt-to-Equity Ratio: | 19.4 |
|---|---|
| Current Ratio: | 6.24 |
| Quick Ratio: | 5.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PACB Technical Analysis vs Fundamental Analysis
Buy
71
Pacific Biosciences of California, Inc. (PACB)
is a Buy
Is Pacific Biosciences of California, Inc. a Buy or a Sell?
-
Pacific Biosciences of California, Inc. stock is rated a BuyThe current Pacific Biosciences of California, Inc. [PACB] share price is $2.52. The Score for PACB is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.